Decorative image

Targeted cancer drugs

You might have one or more of these targeted cancer drugs for advanced kidney cancer. You might have them as part of a clinical trial.

Sunitinib (Sutent)

Find out what sunitinib is, how you have it and other important information about taking this cancer drug. 

Pazopanib (Votrient)

Read about pazopanib, how you have it and other important information about taking this cancer drug for advanced kidney cancer. 

Aldesleukin (IL-2, Proleukin or interleukin 2)

Read about aldesleukin, how you have it and other important information about taking this cancer drug. 

Interferon (Intron A)

Find out what interferon is, how you have it and other important information about taking this biological therapy for cancer. 

Bevacizumab (Avastin)

Find out what bevacizumab (Avastin) is, how you have it and other important information about having bevacizumab (Avastin) for advanced kidney cancer.

Everolimus (Afinitor)

Find out what everolimus is, how you have it and other important information about taking this cancer drug. 

Temsirolimus (Torisel)

Read about temsirolimus, how you have it and other important information about taking this biological therapy drug for advanced kidney cancer. 

Axitinib (Inlyta)

Find out what axitinib is, how you have it and other important information about taking axitinib for advanced kidney cancer.

Cabozantinib (Cometriq, Cabometyx)

Cabozantinib is a type of targeted drug. It is a treatment for advanced kidney and medullary thyroid cancer.

    Ipilimumab and nivolumab

    Find out about the drug combination ipilimumab and nivolumab, how you have it, what the possible side effects are and other important information.

    Last reviewed: 
    30 Jan 2019

    Information and help